title: Improvement of peak shape and separation performance of beta-blockers in conventional reversed-phase columns using solvent modifiers.
abstract: A comparative study of peak shape, elution behavior, and resolution of 16 beta-blockers (acebutolol, alprenolol, atenolol, bisoprolol, carteolol, celiprolol, esmolol, labetalol, metoprolol, nadolol, oxprenolol, pindolol, practolol, propranolol, sotalol, and timolol) chromatographed with hybrid mobile phases of triethylamine (TEA)-acetonitrile and sodium dodecyl sulfate (SDS)-propanol is performed using conventional reversed-phase columns and isocratic elution. Both solvent modifiers (TEA and SDS) prevent the interaction of the basic drugs with the alkyl-bonded phase. However, the protection mechanisms of silanols on the packing are different. Whereas TEA associates with the silanol sites (blocking ion-exchange processes or repelling the solutes), the long hydrophobic chain of SDS is inserted in the bonded organic layer with the sulfate group protruding outside, which makes the stationary phase negatively charged. The effects of TEA, acetonitrile, SDS, and propanol on the elution strength, efficiency, peak asymmetry, and resolution are examined under an experimental design basis that is assisted by computer simulation to reach more general conclusions. The combination of improved peak shapes, larger selectivity, and a smaller range in retention among compounds of extreme polarity leads to the observation that a greater number of beta-blockers can be resolved with a hybrid micellar system.
authors.affiliation: Departament de Química Analítica, Facultat de Química, Universitat de València, Dr. Moliner 50, 46100 Burjassot (València), Spain.
authors.forename: M J
authors.initials: MJ
authors.lastname: Ruiz-Angel
authors.forename: J R
authors.initials: JR
authors.lastname: Torres-Lapasió
authors.forename: S
authors.initials: S
authors.lastname: Carda-Broch
authors.forename: M C
authors.initials: MC
authors.lastname: García-Alvarez-Coque
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D012997:Solvents / Q000737:chemistry*; D013056:Spectrophotometry, Ultraviolet
chemical_list: D000319:Adrenergic beta-Antagonists; D012997:Solvents